The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunedin Ent.it. Regulatory News (DNE)

Share Price Information for Dunedin Ent.it. (DNE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 490.00
Bid: 474.00
Ask: 500.00
Change: 9.00 (1.87%)
Spread: 26.00 (5.485%)
Open: 490.00
High: 490.00
Low: 490.00
Prev. Close: 481.00
DNE Live PriceLast checked at -
Dunedin Enterprise is an Investment Trust

To conduct an orderly realisation of its assets, to be effected in a manner that seeks to achieve a balance between maximising the value of the investments and progressively returning cash to Shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dunedin Enterprise Investment Trust

23 Oct 2013 10:07

RNS Number : 1870R
Dunedin Enterprise Inv Trust PLC
23 October 2013
 

 

 

 

 

For release 09:00 23 October 2013

 

Dunedin Enterprise Investment Trust PLC

 

 

Dunedin Enterprise Investment Trust PLC ("Dunedin Enterprise") has now completed the exit from its investment in Practice Plan at the level previously indicated. Practice Plan is a leading UK provider of membership plans and other support services to dental practices. The sale to Wesleyan Assurance Society had been subject to regulatory approval which has now been granted. This represents the third portfolio exit for Dunedin Enterprise this year, following the sale of its investment in FSN Capital in May 2013 and in Egeria in February 2013.

 

Total proceeds from the investment on completion will amount to £14.9m, consisting of capital of £9.0m and income of £5.9m.

 

The cost of the investment at 30 June 2013 was £5.6m. The capital gain on realisation of the investment amounts to £3.4m, at least 50% of which (£1.7m) will be returned to shareholders in due course.

 

Dunedin, the manager of Dunedin Enterprise, backed the MBO of Practice Plan in September 2005. In October 2011 Practice Plan acquired Isoplan, a UK dental plan provider, and Medenta, the market leader in dental patient finance.

 

ENDS

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFEMSUDFDSESS
Date   Source Headline
7th May 20245:37 pmRNSHolding(s) in Company
1st May 20247:00 amRNSPreliminary Unaudited Net Asset Value at 31/3/24
22nd Mar 20247:00 amRNSAnnual Financial Report
5th Feb 20241:58 pmRNSHolding(s) in Company
5th Feb 20241:56 pmRNSHolding(s) in Company
5th Feb 20241:54 pmRNSHolding(s) in Company
1st Feb 20247:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/23
19th Dec 20232:34 pmRNSHolding(s) in Company
19th Dec 20232:22 pmRNSHolding(s) in Company
13th Dec 20237:00 amRNSDividend Declaration
21st Nov 20237:00 amRNSPremier Hytemp realisation & potential winding-up
16th Nov 20237:00 amRNS3rd Quarter Results
6th Nov 20234:33 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSPortfolio Update
1st Nov 20237:00 amRNSPreliminary Unaudited Net Asset Value at 30/9/23
28th Sep 20237:00 amRNSPortfolio Update
15th Sep 20237:00 amRNSHalf-year Report
1st Aug 20237:00 amRNSPreliminary unaudited net asset value at 30/6/23
6th Jun 20239:01 amRNSHolding(s) in Company
22nd May 202310:05 amRNSHolding(s) in Company
10th May 20232:42 pmRNSResult of AGM
10th May 20232:42 pmRNS1st Quarter Results
2nd May 20237:00 amRNSPreliminary unaudited net asset value at 31/3/23
24th Mar 20237:00 amRNSAnnual Financial Report
1st Feb 20237:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/22
7th Dec 20221:02 pmRNSDirector/PDMR Shareholding
7th Dec 20221:00 pmRNSDirector/PDMR Shareholding
7th Dec 20221:00 pmRNSDirector/PDMR Shareholding
6th Dec 202211:12 amRNSDirector/PDMR Shareholding
6th Dec 202211:09 amRNSDirector/PDMR Shareholding
1st Dec 202212:42 pmRNSHolding(s) in Company
30th Nov 20225:50 pmRNSDirector/PDMR Shareholding
30th Nov 20225:48 pmRNSDirector/PDMR Shareholding
30th Nov 202212:10 pmRNSHolding(s) in Company
29th Nov 20225:25 pmRNSHolding(s) in Company
29th Nov 202210:42 amRNSHolding(s) in Company
28th Nov 20229:06 amRNSHolding(s) in Company
25th Nov 20222:32 pmRNSHolding(s) in Company
22nd Nov 20227:00 amRNSResult of Tender Offer
16th Nov 202212:52 pmRNS3rd Quarter Results
16th Nov 202212:49 pmRNSResult of General Meeting
4th Nov 202210:00 amRNSHolding(s) in Company
4th Nov 20228:51 amRNSHolding(s) in Company
1st Nov 20227:00 amRNSQ3 Preliminary NAV and Tender Offer Price
21st Oct 20227:00 amRNSInterim Dividend
21st Oct 20227:00 amRNSTender Offer
7th Oct 20227:00 amRNSPortfolio Update
16th Sep 20227:00 amRNSHalf-year Report
25th Aug 20229:15 amRNSPortfolio Update
1st Aug 20227:00 amRNSPreliminary unaudited net asset value at 30/6/22

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.